Correlation between SDF-1α, CD34 positive hematopoietic stem cells and CXCR4 expression with liver fibrosis in CCl4 rat model

Table 2 The serum level of the liver Enzymes in the 5 study groups

Liver transaminases (median±SE)	Group			One-Way ANOVA		Effect Size
Liver transaminases (median±SE)	Control	4wks CCL4	8wks CCL4	F	p -value	Partial η2 (a)	Cohen’s f
AST (IU/L)	7.82 ± 0.60	124.33 ± 2.56^ab	306.83 ± 6.36^a	1436.809	< 0.001	0.995	14.10674
ALT (IU/L)	7.67 ± 0.45	51.13 ± 2.12^ab	124.5 ± 3.65^a	579.658	<0.001	0.987	8.713385
AST/ALT Ratio	1.02 ± 0.07	2.46 ± 0.13^a	2.47 ± 0.07^a	74.790	<0.001	0.909	3.16054
		2wks reversion	4wks reversion	F	p -value	Partial η2 (b)	Cohen’s f
AST (IU/L)		188.00± 3.37^ab	38.233± 0.55^abc	1470.086	<0.001	0.995	14.10674
ALT (IU/L)		84.38±3.99^ab	27.15±0.94^abc	376.226	<0.001	0.983	7.604178
AST/ALT Ratio		2.25± 0.10^a	1.42± 0.06^b	77.893	<0.001	0.921	3.414415

Partial η2 (a) is a measure of effect size between the groups (control and 4& 8wks CCl4) created by Univariate analysis in a general linear model (GLM)
Partial η2 (b) is a measure of effect size between the groups (control, 8wks CCl4, and 2 & 4wks reversion) created by Univariate analysis in a general linear model (GLM)
^aSubstantial variation VS control group
^bsubstantial variation VS 8wks CCl4 group
^csubstantial variation VS 2wks reversion group

ISSN: 1471-230X